Supreem Pharmaceuticals Mysore Private Limited - Company Profile

It is a healthcare private limited company based in Nanjangudu, Karnataka, India, established in 1996.
1996 Nanjangudu, Karnataka, India Active
Last Updated:
Access Report
About Supreem Pharmaceuticals Mysore Private Limited

Supreem Pharmaceuticals Mysore Private Limited, a active private limited company, was established on 16 August 1996 in Nanjangudu, Karnataka, India. Engaging in preventive health supplements within the manufacturing sector, it holds CIN: U24231KA1996PTC020988. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹5.50 Cr and a paid-up capital of ₹3.94 Cr.

Formerly known as Candor Laboratories Limited, Candor Labs Private Limited.. It upholds a compliant status. Employing 207 professional, Its leadership includes Geetha Sadananda Nagaraja Rao (Whole-Time Director), Aditya Sadanand Rao (Whole-Time Director), Amit Sadanand Rao (Whole-Time Director). Past directors included Geetha Sadananda Nagaraja Rao, Sunil Mundra Laxminarayana, Venkatesh Tammiah Avadhany. It holds ₹44.24 Cr open charges and ₹6.70 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at # 73, 74 & 48P1, Kiadb Industrial Area,, Nanjangudu, Karnataka, 571302.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231KA1996PTC020988

  • Registration Number

    020988

  • Incorporation Date

    16 August 1996

  • Authorized Capital

    ₹5.50 Cr

  • Paid-Up Capital

    ₹3.94 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.50 Cr
  • Paid Up Capital ₹ 3.94 Cr
  • Company Age 29 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 44.24 Cr
  • Satisfied Charges ₹ 6.70 Cr
  • Revenue Growth **** 7.32%
  • Profit Growth **** -617.53%
  • Ebitda **** -212.16%
  • Net Worth -46.82%
  • Total Assets **** 14.40%
Company report

Supreem Pharmaceuticals Mysore Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Supreem Pharmaceuticals Mysore Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Supreem Pharmaceuticals Mysore Private Limited?
Current Directors
Name Designation Appointment Date Status
Geetha Sadananda Nagaraja Rao Whole-Time Director 22 Jan 2008 Current
Aditya Sadanand Rao Whole-Time Director 10 Jul 2020 Current
Amit Sadanand Rao Whole-Time Director 10 Jul 2020 Current
Sadanand Nagaraja Rao Managing Director 16 Aug 1996 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 10 Apr 2020 Past
Pramod Abcsdd Director 31 Aug 2020 Past
Pramod Abcsdd Director 15 Nov 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Supreem Pharmaceuticals Mysore.

Supreem Pharmaceuticals Mysore Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.32% increase. The company also saw a substantial fall in profitability, with a 617.53% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.82%.

Supreem Pharmaceuticals Mysore revenue growth over time
Supreem Pharmaceuticals Mysore profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 7.32%
*******
*******
*******
*******
Revenue from Operations
*******
 7.25%
*******
*******
*******
*******
Total Assets
*******
 14.40%
*******
*******
*******
*******
Profit or Loss
*******
 -617.53%
*******
*******
*******
*******
Net Worth
*******
 -46.82%
*******
*******
*******
*******
EBITDA
*******
 -212.16%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Supreem Pharmaceuticals Mysore?

In 2023, Supreem Pharmaceuticals Mysore had a promoter holding of 61.84% and a public holding of 38.16%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹442,425,000.00

Satisfied Charges

₹67,000,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 30.00 Cr
  • Karnataka State Financial Corporation : 8.30 Cr
  • Axis Bank Limited : 5.94 Cr
Latest Charge Details
Date Lender Amount Status
11 Jul 2023 Axis Bank Limited ₹5.94 Cr Open
09 Oct 2013 Karnataka State Financial Corporation ₹8.30 Cr Open
21 Nov 2007 State Bank Of India ₹29.65 Cr Open
20 Sep 2002 State Bank Of India ₹3.53 M Open
04 Mar 2015 Karnataka State Financial Corporation ₹2.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Supreem Pharmaceuticals Mysore?

Supreem Pharmaceuticals Mysore has a workforce of 207 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Supreem Pharmaceuticals Mysore, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supreem Pharmaceuticals Mysore's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Supreem Pharmaceuticals Mysore
Recent Activity within the Organization
  • Charges

    The activity A charge with Axis Bank Limited of Rs. 5.94 Cr registered on 11 Jul 2023 with Charge ID 100788923 was modified on 13 Nov 2025. was completed.

  • Annual General Meeting

    The activity Supreem Pharmaceuticals Mysore Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Supreem Pharmaceuticals Mysore Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 5.94 Cr with Charge ID 100788923 was registered on 11 Jul 2023. was recorded as a recent event.

  • Charges

    A charge with State Bank Of India of Rs. 29.65 Cr registered on 21 Nov 2007 with Charge ID 10081897 was modified on 04 Jan 2023. was recorded as a recent event.

  • Director Appointment

    The activity Aditya Sadanand Rao was appointed as a Whole-time director was appointed as a Whole-time director on 10 Jul 2020 & has been associated with this company since 5 years 6 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Supreem Pharmaceuticals Mysore Private Limited?

The CIN of Supreem Pharmaceuticals Mysore Private Limited is U24231KA1996PTC020988.

Where is Supreem Pharmaceuticals Mysore Private Limited headquartered?

Supreem Pharmaceuticals Mysore Private Limited is headquartered at # 73, 74 & 48P1, Kiadb Industrial Area,, Nanjangudu, Karnataka, 571302.

When was Supreem Pharmaceuticals Mysore Private Limited incorporated?

Supreem Pharmaceuticals Mysore Private Limited was incorporated on 16 August 1996.

Who are the current directors of Supreem Pharmaceuticals Mysore Private Limited?

The current directors of Supreem Pharmaceuticals Mysore Private Limited are

What is the primary industry of Supreem Pharmaceuticals Mysore Private Limited?

The primary industry of Supreem Pharmaceuticals Mysore Private Limited is Manufacturing.

Is Supreem Pharmaceuticals Mysore Private Limited a listed company?

Supreem Pharmaceuticals Mysore Private Limited is unlisted.

What is the capital structure of Supreem Pharmaceuticals Mysore Private Limited?

The authorized capital of Supreem Pharmaceuticals Mysore Private Limited is ₹5.50 Cr, and the paid-up capital is ₹3.94 Cr.

What is the compliance status of Supreem Pharmaceuticals Mysore Private Limited?

The compliance status of Supreem Pharmaceuticals Mysore Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available